MAPT and Alzheimer disease: Methionine sulfoxide at Aβ and numerous tau protein phosphorylation sites in the insoluble proteins characteristic for Alzheimer’s disease were identified, while no post-translational modifications were enriched with ApoE or GFAP (Boutte et al. 2006).